SCHEMBL3440698

SCHEMBL3440698

Sc1cccc(Cc2ccccc2)c1

nearest known ligand 0.57

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CALM1 P0DP23 1/20 0.57
IDH1 O75874 1/20 0.48
PRSS1 P07477 1/20 0.47
PRSS2 P07478 1/20 0.47
PRSS3 P35030 1/20 0.47
BCL2 P10415 1/20 0.41
BCL2L1 Q07817 1/20 0.41
HNF4A P41235 1/20 0.41
IDO1 P14902 1/20 0.40
SLC5A2 P31639 1/20 0.40
LOXL2 Q9Y4K0 1/20 0.40
LTA4H P09960 1/20 0.40
ACMSD Q8TDX5 1/20 0.40
MTNR1A P48039 1/20 0.39
MTNR1B P49286 1/20 0.39
PLA2G10 O15496 1/20 0.38
PLA2G2A P14555 1/20 0.38
LMNA P02545 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11781101 0.93 CALM1 (0.43) CALM1IDH1PRSS1PRSS2PRSS3
Diphenylmethane SCHEMBL6200261 0.85 CALM1 (0.71) CALM1IDH1BCL2BCL2L1IDO1
SCHEMBL23864832 0.83 SLC5A2 (0.46) CALM1IDH1IDO1SLC5A2LTA4H
SCHEMBL7613502 0.82 CALM1 (0.75) CALM1IDH1PRSS1PRSS2PRSS3
SCHEMBL13971231 0.82 CALM1 (0.75) CALM1IDH1PRSS1PRSS2PRSS3
SCHEMBL25720257 0.80 PNMT (0.52) IDO1
SCHEMBL21380590 0.79 BCL2 (0.36) CALM1BCL2BCL2L1
SCHEMBL338117 0.77 CALM1 (0.67) CALM1IDH1BCL2BCL2L1HNF4A
SCHEMBL22316245 0.76 CYP2C19 (0.41) IDO1
Diphenylmethane SCHEMBL14763944 0.76 CALM1 (1.00) CALM1IDH1BCL2BCL2L1IDO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 14 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110386887-A A kind of preparation method of 3- benzylthio phenol intermediate 南京格亚医药科技有限公司 2019-10-29 CN claimed
CN-110386887-A A kind of preparation method of 3- benzylthio phenol intermediate 南京格亚医药科技有限公司 2019-10-29 CN disclosed
CN-110386887-A A kind of preparation method of 3- benzylthio phenol intermediate 南京格亚医药科技有限公司 2019-10-29 CN disclosed
CN-110386887-A A kind of preparation method of 3- benzylthio phenol intermediate 南京格亚医药科技有限公司 2019-10-29 CN disclosed
CN-104277051-B 4 aminothiophenes simultaneously [3,2 C] carboxylic acid derivates of pyridine 7 霍夫曼-拉罗奇有限公司 2017-06-09 CN disclosed
CN-101263145-B 4-amino-thieno [3,2-C ] pyridine-7-carboxylic acid derivatives HOFFMANN LA ROCHE 2015-02-25 CN disclosed
CN-104277051-A 4-amino-thieno[3,2-c] pyridine-7-carboxylic acid derivatives HOFFMANN LA ROCHE 2015-01-14 CN disclosed
US-7807713-B2 Pan-antagonists for the androgen receptor and androgen associated with anti-androgen withdrawal UNIVERSITY OF DELAWARE (US) 2010-10-05 US disclosed
US-20090270512-A1 Pan-Antagonists For The Androgen Receptor And Androgen Receptor Mutants Associated With Anti-Androgen Withdrawal NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2009-10-29 US disclosed
US-7550505-B2 Pan-antagonists for the androgen receptor and androgen receptor mutants associated with anti-androgen withdrawal UNIVERSITY OF DELAWARE (US) 2009-06-23 US disclosed
CN-101263145-A 4-amino-thieno [3, 2-C ] pyridine-7-carboxylic acid derivatives HOFFMANN LA ROCHE (CH) 2008-09-10 CN disclosed
US-20080064757-A1 Pan-antagonists for the androgen receptor and androgen receptor mutants associated with anti-androgen withdrawal NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT 2008-03-13 US disclosed
WO-2008013791-A2 PAN-ANTAGONISTS FOR THE ANDROGEN RECEPTOR AND ANDROGEN RECEPTOR MUTANTS ASSOCIATED WITH ANTI-ANDROGEN WITHDRAWAL UNIVERSITY OF DELAWARE (US) 2008-01-31 WO disclosed
EP-0872504-A1 CURABLE EPOXY RESIN COMPOSITION WHICH GIVES FLEXIBLE CURED ARTICLE ASAHI DENKA KOGYO KABUSHIKI KAISHA (JP) 1998-10-21 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090270512-A1 Pan-Antagonists For The Androgen Receptor And Androgen Receptor Mutants Associated With Anti-Androgen Withdrawal AR, NR5A1, SHBG CALM1 4155/4885IDH1 3355/4885PRSS1 545/4885
US-20080064757-A1 Pan-antagonists for the androgen receptor and androgen receptor mutants associated with anti-androgen withdrawal AR, NR5A1, SHBG CALM1 4155/4885IDH1 3355/4885PRSS1 545/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.